Skip to main content

Anemia in the Critically Ill

  • Chapter
  • First Online:
Hematologic Challenges in the Critically Ill
  • 684 Accesses

Abstract

Anemia is one of the most important health-care problems of our time. As an entity per se, anemia is independently associated with significant morbidity and mortality. However, the reasons for anemia are manifold, and as a consequence, the symptom of “anemia” is also the final path of many different diseases. At the intensive care unit, the etiologies for anemia include blood loss due to bleeding, diagnostic blood withdrawal, red blood cell breakdown due to immune hemolytic anemias, or other types of hemoglobinopathies, or limited erythropoiesis due to nutritional deficiencies, or inflammation and inflammation-induced utilization disturbances of iron. Diagnosis of these entities requires adequate knowledge of the underlying pathophysiologies. The most obvious treatment of acute anemia, the transfusion of red blood cells, does not necessarily result in reduced morbidity and mortality, and as a consequence, other means to increase the red cell mass such as the application of iron or exogenous erythropoietin have gained more and more scientific interest.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014 Jan 30;123(5):615–24.

    Article  CAS  Google Scholar 

  2. Lasocki S, Chudeau N, Papet T, Tartiere D, Roquilly A, Carlier L, et al. Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study. Crit Care. 2014;18(5):542.

    Article  Google Scholar 

  3. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med. 2004 Jan;32(1):39–52.

    Article  Google Scholar 

  4. Vincent JL, Baron J-F, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002 Sep 25;288(12):1499–507.

    Article  Google Scholar 

  5. Janz TG, Johnson RL, Rubenstein SD. Anemia in the emergency department: evaluation and treatment. Emerg Med Pract. 2013 Nov;15(11):1–15; quiz 15–16.

    Google Scholar 

  6. Dyke C, Aronson S, Dietrich W, Hofmann A, Karkouti K, Levi M, et al. Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg. 2014;147(5):1458–1463.e1.

    Article  Google Scholar 

  7. Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical review: hemorrhagic shock. Crit Care. 2004;8(5):373–81.

    Article  Google Scholar 

  8. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801–10.

    Article  CAS  Google Scholar 

  9. Chakraverty R, Davidson S, Peggs K, Stross P, Garrard C, Littlewood TJ. The incidence and cause of coagulopathies in an intensive care population. Br J Haematol. 1996 May;93(2):460–3.

    Article  CAS  Google Scholar 

  10. Alshamsi F, Belley-Cote E, Cook D, Almenawer SA, Alqahtani Z, Perri D, et al. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care. 2016 May 4;20(1):120. Available from: http://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1305-6

  11. Lyon AW, Chin AC, Slotsve GA, Lyon ME. Simulation of repetitive diagnostic blood loss and onset of iatrogenic anemia in critical care patients with a mathematical model. Comput Biol Med. 2013 Feb;43(2):84–90.

    Article  Google Scholar 

  12. Koch CG, Reineks EZ, Tang AS, Hixson ED, Phillips S, Sabik JF, et al. Contemporary bloodletting in cardiac surgical care. Ann Thorac Surg. 2015 Mar;99(3):779–84.

    Article  Google Scholar 

  13. Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015 Dec 1;102(6):1585–94.

    Article  CAS  Google Scholar 

  14. Piagnerelli M, Cotton F, Herpain A, Rapotec A, Chatti R, Gulbis B, et al. Time course of iron metabolism in critically ill patients. Acta Clin Belg. 2013 Jan;68(1):22–7.

    Article  CAS  Google Scholar 

  15. Rossi E. Hepcidin-the iron regulatory hormone. Clin Biochem Rev. 2005;26(3):47–9.

    PubMed  PubMed Central  Google Scholar 

  16. Napolitano LM. Anemia and red blood cell transfusion. Crit Care Clin. 2017 Apr;33(2):345–64.

    Article  Google Scholar 

  17. Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC. Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth Intensive Care. 2001 Oct;29(5):473–8.

    CAS  PubMed  Google Scholar 

  18. Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf. 2012 Jul;11(4):635–42.

    Article  CAS  Google Scholar 

  19. Kohne E. Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Dtsch Ärztebl Int. 2011;108(31–32):532–40.

    PubMed  PubMed Central  Google Scholar 

  20. Wada T, Hagiwara A, Uemura T, Yahagi N, Kimura A. Early lactate clearance for predicting active bleeding in critically ill patients with acute upper gastrointestinal bleeding: a retrospective study. Intern Emerg Med. 2016 Aug;11(5):737–43.

    Article  Google Scholar 

  21. Shah A, Chisolm-Straker M, Alexander A, Rattu M, Dikdan S, Manini AF. Prognostic use of lactate to predict inpatient mortality in acute gastrointestinal hemorrhage. Am J Emerg Med. 2014 Jul;32(7):752–5.

    Article  Google Scholar 

  22. Gale SC, Kocik JF, Creath R, Crystal JS, Dombrovskiy VY. A comparison of initial lactate and initial base deficit as predictors of mortality after severe blunt trauma. J Surg Res. 2016 Oct;205(2):446–55.

    Article  CAS  Google Scholar 

  23. Meier J, Filipescu D, Kozek-Langenecker S, Llau Pitarch J, Mallett S, Martus P, et al. Intraoperative transfusion practices in Europe. Myles PS, editor. Br J Anaesth. 2016 Feb;116(2):255–61.

    Article  CAS  Google Scholar 

  24. Wintrobe MM. Relation of variations in mean corpuscular volume to number of reticulocytes in pernicious anemia. J Clin Invest. 1934 Jul 1;13(4):669–76.

    Article  CAS  Google Scholar 

  25. Buttarello M. Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how? Int J Lab Hematol. 2016 May;38:123–32.

    Article  Google Scholar 

  26. Brugnara C, Adamson J, Auerbach M, Kane R, Macdougall I, Mast A. Iron deficiency: what are the future trends in diagnostics and therapeutics? Clin Chem. 2013;59(5):740–5.

    Article  CAS  Google Scholar 

  27. Lasocki S, Longrois D, Montravers P, Beaumont C. Hepcidin and anemia of the critically ill patient: bench to bedside. Anesthesiology. 2011 Mar;114(3):688–94.

    Article  Google Scholar 

  28. Pieracci FM, Henderson P, Rodney JRM, Holena DN, Genisca A, Ip I, et al. Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect. 2009 Feb;10(1):9–19.

    Article  Google Scholar 

  29. Pieracci FM, Stovall RT, Jaouen B, Rodil M, Cappa A, Burlew CC, et al. A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*. Crit Care Med. 2014 Sep;42(9):2048–57.

    Article  CAS  Google Scholar 

  30. Litton E, Baker S, Erber W, French C, Ferrier J, Hawkins D, et al. The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia. Crit Care Resusc. 2014;16(4):285–90.

    PubMed  Google Scholar 

  31. Shah A, Roy NB, McKechnie S, Doree C, Fisher SA, Stanworth SJ. Iron supplementation to treat anaemia in adult critical care patients: a systematic review and meta-analysis. Crit Care. 2016 Sep 29;20(1):306. Available from: http://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1486-z

  32. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013;347:f4822.

    Article  Google Scholar 

  33. Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations. Mayo Clin Proc. 2015 Jan;90(1):12–23.

    Article  Google Scholar 

  34. Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA. 2014 Apr;311(13):1317–26.

    Article  CAS  Google Scholar 

  35. Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med. 2007 Sep;357(10):965–76.

    Article  CAS  Google Scholar 

  36. Zhao Y, Jiang C, Peng H, Feng B, Li Y, Weng X. The effectiveness and safety of preoperative use of erythropoietin in patients scheduled for total hip or knee arthroplasty. Medicine (Baltimore). 2016;95(27):e4122.

    Article  CAS  Google Scholar 

  37. Mesgarpour B, Heidinger BH, Roth D, Schmitz S, Walsh CD, Herkner H. Harms of off-label erythropoiesis-stimulating agents for critically ill people. Cochrane Anaesthesia, Critical and Emergency Care Group, editor. Cochrane Database Syst Rev. 2017 Aug 25. Available from: http://doi.wiley.com/10.1002/14651858.CD010969.pub2

  38. Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care. 2001 Mar;16(1):36–41.

    Article  CAS  Google Scholar 

  39. Prakash D. Anemia in the ICU. Crit Care Clin. 2012 Jul;28(3):333–43.

    Article  Google Scholar 

  40. Uscinska E, Sobkowicz B, Sawicki R, Kiluk I, Baranicz M, Stepek T, et al. Parameters influencing in-hospital mortality in patients hospitalized in intensive cardiac care unit: is there an influence of anemia and iron deficiency? Intern Emerg Med. 2015 Apr;10(3):337–44.

    Article  Google Scholar 

  41. Uscinska E, Idzkowska E, Sobkowicz B, Musial WJ, Tycinska AM. Anemia in Intensive Cardiac Care Unit patients – an underestimated problem. Adv Med Sci. 2015 Sep;60(2):307–14.

    Article  Google Scholar 

  42. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Annals of internal medicine clinical guideline red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med. 2012;1(157):49–58.

    Article  Google Scholar 

  43. Vamvakas EC, Blajchman MA. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev. 2010 Apr;24(2):77–124.

    Article  Google Scholar 

  44. Napolitano LM, Kurek S, Luchette FA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;37(11):3124–57.

    Article  Google Scholar 

  45. Zimmerman R, Tsai AG, Salazar Vázquez BY, Cabrales P, Hofmann A, Meier J, et al. Posttransfusion increase of hematocrit per se does not improve circulatory oxygen delivery due to increased blood viscosity. Anesth Analg. 2017 May;124(5):1547–54.

    Article  CAS  Google Scholar 

  46. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409–17.

    Article  Google Scholar 

  47. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011 Dec;365(26):2453–62.

    Article  CAS  Google Scholar 

  48. Carson JL, Sieber F, Cook DR, Hoover DR, Noveck H, Chaitman BR, et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet. 2015 Mar 28;385(9974):1183–1189. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25499165

    Article  Google Scholar 

  49. Holst LB. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit. Dan Med J. 2016 Feb;63(2):B5209.

    PubMed  Google Scholar 

  50. Hajjar LA, Vincent J-L, Galas FRBG, Nakamura RE, Silva CMP, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010 Oct;304(14):1559–67.

    Article  CAS  Google Scholar 

  51. Mazer CD, Whitlock RP, Fergusson DA, Hall J, Belley-Cote E, Connolly K, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017 Nov 30;377(22):2133–2144. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1711818

    Article  Google Scholar 

  52. Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11–21.

    Article  CAS  Google Scholar 

  53. Bergamin FS, Almeida JP, Landoni G, Galas FRBG, Fukushima JT, Fominskiy E, et al. Liberal versus restrictive transfusion strategy in critically ill oncologic patients. Crit Care Med. 2017;45(5):766–73.

    Article  Google Scholar 

  54. Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J. 2013 Jun;165(6):964–971.e1.

    Article  Google Scholar 

  55. Wang WC, Dwan K. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. In: The Cochrane Collaboration, editor. Cochrane database of systematic reviews. Chichester, UK: Wiley; 2013. Available from: http://doi.wiley.com/10.1002/14651858.CD003146.pub2.

    Google Scholar 

  56. Estcourt LJ, Fortin PM, Trivella M, Hopewell S. Preoperative blood transfusions for sickle cell disease. In: The Cochrane Collaboration, editor. Cochrane database of systematic reviews. Chichester, UK: Wiley; 2016. Available from: http://doi.wiley.com/10.1002/14651858.CD003149.pub3.

    Google Scholar 

  57. Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, et al. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME): Transfusion Complications in Thalassemia. Transfusion (Paris). 2014 Apr;54(4):972–81.

    Article  CAS  Google Scholar 

  58. Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2016 Oct;10(5):CD002042.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jens Meier .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Meier, J. (2018). Anemia in the Critically Ill. In: Shander, A., Corwin, H. (eds) Hematologic Challenges in the Critically Ill. Springer, Cham. https://doi.org/10.1007/978-3-319-93572-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-93572-0_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-93571-3

  • Online ISBN: 978-3-319-93572-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics